Stuart Iain has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 2876 shares of VYNE Therapeutics Inc. ($VYNE) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2876 | $0.60 | 112,363.0000 | 42,589,000 | 2.50% | 0.01% |
| Dec. 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2448 | $0.58 | 115,239.0000 | 42,589,000 | 2.08% | 0.01% |
| Sept. 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2453 | $0.34 | 117,687.0000 | 42,589,000 | 2.04% | 0.01% |
| June 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 2453 | $1.65 | 120,140.0000 | 42,589,000 | 2.00% | 0.01% |
| March 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 6044 | $1.58 | 122,593.0000 | 42,589,000 | 4.70% | 0.01% |
| Jan. 21, 2025 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 42,589,000 | 9999.99% | 0.54% |
| Dec. 31, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 4857 | $3.35 | 128,637.0000 | 10,273,000 | 3.64% | 0.05% |
| Sept. 30, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 109 | $1.88 | 133,494.0000 | 10,273,000 | 0.08% | 0.00% |
| July 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 138 | $1.92 | 133,603.0000 | 10,273,000 | 0.10% | 0.00% |
| April 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 157 | $3.08 | 133,741.0000 | 10,273,000 | 0.12% | 0.00% |
| Jan. 2, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | Chief Scientific Officer | F | Common Stock | 157 | $2.28 | 133,898.0000 | 10,273,000 | 0.12% | 0.00% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | Chief Scientific Officer | A | Stock Option (right to buy) | 62500 | $0.00 | 62,500.0000 | 10,273,000 | 9999.99% | 0.61% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Stuart Iain | Chief Scientific Officer | A | Common Stock | 62500 | $0.00 | 134,055.0000 | 10,273,000 | 87.35% | 0.61% |